Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma.
Ellery AltshulerMahmoud AryanGovind KallumkalHanzhi GaoJake WilsonAhmed OuniEdward De LeoWissam HanaynehKelsey PanPublished in: Hepatic oncology (2022)
Although the authors' study did not demonstrate that BBs improve OS in HCC, it did show decreased disease progression among patients with HCC who were taking BBs compared with those who were not.